Claudia Iannone, MD

University of Milan, Gaetano Pini CTO
Milano, Milan, Italy

Rheumatology Resident in Milan
ASST-PINI CTO

Presentation(s):

• 1863: bag3 in Systemic Sclerosis: Possible Therapeutic Target and Biomarker for Pulmonary Fibrosis

  Tuesday, October 28, 2025
  10:30 AM - 12:30 PM Central Time

  Disclosure(s): No financial relationships with ineligible companies to disclose

• 2656: Long-term effect of selexipag in systemic sclerosis-associated digital ulcers: a case control, multicentre, observational study

  Wednesday, October 29, 2025
  10:45 AM - 11:00 AM Central Time

  Disclosure(s): No financial relationships with ineligible companies to disclose